DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20174615

Hemophagocytic syndrome, a rare variant of Still’s disease

Neha Bhave, Dinesh Gupta, Prashant Kashyap

Abstract


Adult onset still’s disease is a rare systemic inflammatory disorder of unknown etiology that is responsible for a significant number of cases of fever of unknown origin (FUO) and musculoskeletal diseases. The diagnosis in adult onset still’s disease is mainly clinical and requires exclusion of other infections. Laboratory tests are nonspecific and treatment mainly comprises of corticosteroids, NSAIDS, immunosuppressive drugs, iv gamma globulin, anti-tumour necrosis factor, anti-interleukin. AOSD (adult onset stills disease) is a diagnostic challenge. Discovery of new serological tests and a specific diagnostic criterion may help the clinician in faster diagnosis and better management of the disease. 


Keywords


AOSD (adult onset stills disease), Fever of unknown origin (FUO)

Full Text:

PDF

References


Giampietro C, Fautrel B. Anti-interleukin-1 agents in adult onset Still's disease. Int J Inflammation. 2012;2012.

Jose CC. Martinez-Banos D, Alcocer-Varela J. Adult-onset Still disease as the cause of fever of unknown origin. Medic. 2005;84(6):331-7.

Arnow PM, Flaherty JP. Fever of unknown origin. Lancet. 1997;350(9077):575-80.

Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol. 1992;19(3):424-30.

Olive A, Junca J, Tena X. Ferritin and adult Still’s disease. Br J Rheumatol. 1991;30(2):158.

Arvidson NG, Gudbiornsson B, Elfman L, Ryden AC, Totterman, TH, Hallgren R. Circadian rhythm of serum interleukin-6 in rheumatoid arthritis. Ann Rheum Dis. 1994;53:521-24.

David J, Davies U, Rooney M. Cytokine measurement in juvenile chronic arthritis (JCA). Arthritis Rheum. 1990;33(9):S118-99.

Owlia MB, Mehrpoor G. Adult- onset Still's disease: a review. Indian J Med Sci. 2009;63(5):207-21.

Elliott MJ, Woo P, Charles P, Long-Fox A, Woody JN, Maini RN. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). Br J Rheumatol. 1997;36(5):589-93.

Cavagna L, Caporali R, Epis O, Bobbio-Pllavicini F, Montecucco C. Infliximab in the treatment of adult Still’s disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19:329-32.